2023
DOI: 10.1016/j.jmbbm.2023.105668
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the structures contribution (crystalline and mesophases) and mechanical properties of polycaprolactone/pluronic blends

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 49 publications
1
7
0
Order By: Relevance
“…Three distinct diffraction peaks characteristic of the PLA crystalline α phase were visible in the XRD pattern of the pure PLA film at 2θ angles of 16.8°, 19.2° and 22.6° [ 45 , 46 ]. The XRD pattern for the PCL film showed strong diffraction peaks at 21.4° and 23.7° 2θ, which is consistent with the literature [ 47 , 48 , 49 ]. The PLA/PCL film showed main diffraction peaks corresponding to the PLA crystalline α phase at 16.8° and 19.2° 2θ and no visible diffraction peaks related to crystalline PCL ( Figure 7 a).…”
Section: Resultssupporting
confidence: 91%
“…Three distinct diffraction peaks characteristic of the PLA crystalline α phase were visible in the XRD pattern of the pure PLA film at 2θ angles of 16.8°, 19.2° and 22.6° [ 45 , 46 ]. The XRD pattern for the PCL film showed strong diffraction peaks at 21.4° and 23.7° 2θ, which is consistent with the literature [ 47 , 48 , 49 ]. The PLA/PCL film showed main diffraction peaks corresponding to the PLA crystalline α phase at 16.8° and 19.2° 2θ and no visible diffraction peaks related to crystalline PCL ( Figure 7 a).…”
Section: Resultssupporting
confidence: 91%
“…To provide a prolonged protection and the controlled release of the inhibitor when the protective layer is damaged in a corrosive environment, the microcontainers within the PEO coating were sealed by a biodegradable polymer, polycaprolactone (PCL) [ 31 , 32 ]. Polycaprolactone is an FDA-approved [ 33 , 34 ] biopolymer material, commonly used in surgery and tissue engineering, as well as for the design of drug-delivery systems [ 35 , 36 , 37 , 38 ]. Considering the use of the material in medical practice, it can be concluded that PCL provides biocompatibility, an appropriate rate of biodegradation with non-toxic degradation products, processability, and accessibility [ 31 , 33 , 39 ].…”
Section: Introductionmentioning
confidence: 99%
“…Such splitting was also reported in the literature on PCL/Pluoronics blends that are immersed in water inside hermetic containers for a duration of 1 year. [ 61 ] In the case of lysozyme‐derivatized PCL films, the derivatization process was found to result in an increase in the intensity of the (200) plane, almost equal to that of (110). This could be correlated to the highest percentage of crystallinity through DTA measurements observed for this sample among all the controls.…”
Section: Resultsmentioning
confidence: 99%